Ye Q, Jiang Z, Xie Y, Xu Y, Ye Y, Ma L, Pei L. MY11 exerts antitumor effects through activation of the NF-κB/PUMA signaling pathway in breast cancer. Invest New Drugs 2022;40:922-33. [PMID: 35759135 DOI: 10.1007/s10637-022-01272-0][Reference Citation Analysis]